ConductScience.org, home

Paper28747713

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).

Kumari S and 4 others. Sci Rep, 2017. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). Papers, record 28747713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28747713

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
PubMed
Journal
Sci Rep
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
5.51
iCite
Revised in PubMed
2022-03-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumari SSonali
2Ahsan SMSaad Mhttps://orcid.org/0000-0002-3337-2076
3Kumar JMJerald M
4Kondapi AKAnand K
5Rao NMNalam M

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, AlkylatingMajor topic
Blood-Brain BarrierMajor topic
Drug CarriersMajor topic
GliomaMajor topic
LactoferrinMajor topic
TemozolomideMajor topic
Animals
Cell Line, Tumor
Mice
Nanoparticles
Treatment Outcome

Source PubMed

Download CSV of topics

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126461917Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.PLoS One2015https://conductscience.org/library/papers/26461917PubMed
227864056Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy.Int J Biol Macromol2017https://conductscience.org/library/papers/27864056PubMed
310536244Preparation and in vitro characterization of HSA-mPEG nanoparticles.Int J Pharm1999https://conductscience.org/library/papers/10536244PubMed
419149575Recent approaches to improve the antitumor efficacy of temozolomide.Curr Med Chem2009https://conductscience.org/library/papers/19149575PubMed
520925470Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.Expert Rev Neurother2010https://conductscience.org/library/papers/20925470PubMed
621988793Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.Mol Cancer2011https://conductscience.org/library/papers/21988793PubMed
720680664Structural characteristic, pH and thermal stabilities of apo and holo forms of caprine and bovine lactoferrins.Biometals2010https://conductscience.org/library/papers/20680664PubMed
810601688Desolvation process and surface characterisation of protein nanoparticles.Int J Pharm2000https://conductscience.org/library/papers/10601688PubMed
926325605Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.Cancer Lett2015https://conductscience.org/library/papers/26325605PubMed
1026186026In vitro and in vivo effect of human lactoferrin on glioblastoma growth.J Neurosurg2015https://conductscience.org/library/papers/26186026PubMed
1127151598Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles.Sci Rep2016https://conductscience.org/library/papers/27151598PubMed
1218653231Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation.Biomaterials2008https://conductscience.org/library/papers/18653231PubMed
1326149889Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.Mol Pharm2015https://conductscience.org/library/papers/26149889PubMed
1426149830Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft.Drug Metab Dispos2015https://conductscience.org/library/papers/26149830PubMed
1522122467Temozolomide: mechanisms of action, repair and resistance.Curr Mol Pharmacol2012https://conductscience.org/library/papers/22122467PubMed
1625088498Carboplatin loaded protein nanoparticles exhibit improve anti-proliferative activity in retinoblastoma cells.Int J Biol Macromol2014https://conductscience.org/library/papers/25088498PubMed
171739631Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).Br J Cancer1992https://conductscience.org/library/papers/1739631PubMed
1817048089Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain.J Biomed Sci2007https://conductscience.org/library/papers/17048089PubMed
1925950506Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy.ACS Nano2015https://conductscience.org/library/papers/25950506PubMed
2025906059Chemotherapy in glioma.CNS Oncol2015https://conductscience.org/library/papers/25906059PubMed

See all 58 referencesDownload CSV of references

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
42941995Lactoferrin and Nanotechnology: New Perspectives and Therapeutic Applications for This Multifunctional Protein.Int J Mol Sci2026https://conductscience.org/library/papers/42941995PubMed
42828315Bevacizumab-Functionalized Exosome-Associated Chitosan Nanocomposite for Temozolomide Delivery and Apoptosis-Related Transcriptional Modulation in Experimental Glioma.Int J Nanomedicine2026https://conductscience.org/library/papers/42828315PubMed
42740496Lactoferrin and Nanotechnology: New Insights Into Glioblastoma Therapy.CNS Neurosci Ther2026https://conductscience.org/library/papers/42740496PubMed
42683315The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition.Front Mol Neurosci2026https://conductscience.org/library/papers/42683315PubMed
42380984BBB-aware stimuli-responsive and biomimetic nanomedicines for glioblastoma.Chin Neurosurg J2026https://conductscience.org/library/papers/42380984PubMed
41872417Design, Optimization, and In Vitro Evaluation of Lactoferrin-Coated Brexpiprazole-Loaded Nanostructured Lipid Carriers for Brain Targeting.AAPS PharmSciTech2026https://conductscience.org/library/papers/41872417PubMed
41809261An erythrocyte membrane-fused plant-derived nanoparticles as a gene therapy vehicle for the treatment of CI/R injury.Asian J Pharm Sci2025https://conductscience.org/library/papers/41809261PubMed
41002483Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.Gels2025https://conductscience.org/library/papers/41002483PubMed
40869046Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer's Disease.Int J Mol Sci2025https://conductscience.org/library/papers/40869046PubMed
40806198Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood-Brain Barrier and Blood-Tumor Barrier.Int J Mol Sci2025https://conductscience.org/library/papers/40806198PubMed
40573304Effect of Acoustic Pressure on Temozolomide-Loaded Oleic Acid-Based Liposomes and Its Safety to Brain Tissue.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40573304PubMed
40313865The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.Adv Pharmacol Pharm Sci2025https://conductscience.org/library/papers/40313865PubMed
40143051Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles.Pharmaceutics2025https://conductscience.org/library/papers/40143051PubMed
40117096Anticancer potential of lactoferrin: effects, drug synergy and molecular interactions.Biometals2025https://conductscience.org/library/papers/40117096PubMed
39524922Temperature and Ultrasound-Responsive Nanoassemblies for Enhanced Organ Targeting and Reduced Cardiac Toxicity.Int J Nanomedicine2024https://conductscience.org/library/papers/39524922PubMed
39403783Ionic liquids and their potential use in development and improvement of drug delivery systems: evidence of their tendency to promote drug accumulation in the brain.Pharm Dev Technol2024https://conductscience.org/library/papers/39403783PubMed
39337556A Novel Tetrahydroacridine Derivative with Potent Acetylcholinesterase Inhibitory Properties and Dissociative Capability against Aβ42 Fibrils Confirmed by In Vitro Studies.Int J Mol Sci2024https://conductscience.org/library/papers/39337556PubMed
38559959Lactoferrin Reduces Surfactant Content in the Self-Emulsifying Drug Delivery System.ACS Omega2024https://conductscience.org/library/papers/38559959PubMed
38275876Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma.Cancers (Basel)2024https://conductscience.org/library/papers/38275876PubMed
38013438Targeted Polymeric Nanoparticles as a Strategy for the Treatment of Glioblastoma: A Review.Curr Drug Deliv2025https://conductscience.org/library/papers/38013438PubMed

See all 69 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ITLN155600PubTator's text mininghttps://conductscience.org/library/genes/55600NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28747713

GET https://conductscience.org/api/papers/v1/28747713/references?page=2